image
INmune Bio, Inc. INMB
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 4.955
-8.92 %
$ 110 M
Market Cap
-2.27
P/E
BALANCE SHEET
57 M ASSETS
-30.31%
Growth Rates
1Year -30.31%
3Years 11.92%
5Years 26.84%
7Years 99.60%
10Years 0.00%
18.9 M LIABILITIES
-13.04%
Growth Rates
1Year -13.04%
3Years 114.82%
5Years 87.05%
7Years 63.62%
10Years 0.00%
38.1 M EQUITY
-36.54%
Growth Rates
1Year -36.54%
3Years -0.53%
5Years 18.19%
7Years 121.02%
10Years 0.00%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition INmune Bio, Inc.
image
Current Assets 39.9 M
Cash & Short-Term Investments 35.8 M
Receivables 2.44 M
Other Current Assets 1.65 M
Non-Current Assets 17.1 M
Long-Term Investments 0
PP&E 414 K
Other Non-Current Assets 16.6 M
Current Liabilities 18.5 M
Accounts Payable 7.9 M
Short-Term Debt 10.2 M
Other Current Liabilities 405 K
Non-Current Liabilities 397 K
Long-Term Debt 397 K
Other Non-Current Liabilities 0

Balance Sheet

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015
ASSETS
Cash & Cash Equivalents 35.8 52.2 74.8 22.0 7.0 0.2 1.4 0.1 11.9 K
Short Term Investments 0 0 0 0 0 0 0 0 0
Receivables 2.4 8.5 5.5 1.8 0.6 0.6 0.3 0.3 0
Inventory 0 34 K (5.5) (2 018.6) (769.1) 0 0 0 0
Other Current Assets 1.7 4.1 2.3 0.2 0.1 15.6 K 42.6 K 3 K 0
Total Current Assets 39.9 64.7 82.6 24.0 7.8 0.8 1.9 0.5 11.9 K
PP&E 0.4 0.5 0.7 0.2 0.2 0 0 0 0
Intangible Assets 16.5 16.5 16.5 16.5 16.5 16.5 16.5 0 0
Goodwill 0 0 0 0 0 0 0 0 0
Long Term Investments 0 0 0 0 0 0 0 0 0
Other Long Term Assets 0.1 99 K 99 K 0 (16.7) 0 0 0 0
Other Assets 0 0 0 0 0 0 0 0 0
Total Assets 57.0 81.8 99.9 40.7 24.5 17.4 18.4 0.5 11.9 K
LIABILITIES
Accounts Payable 7.9 5.2 3.8 1.5 0.4 0.6 0.1 0.2 750
Short Term Debt 10.2 5.2 0.1 34 K 8.29 K 0 0 0.3 0
Other Current Liabilities 0.4 0.5 0.4 0.2 0.3 0.3 0.2 30 K 30 K
Total Current Liabilities 18.5 10.9 4.4 1.8 0.7 0.8 0.3 0.6 30.8 K
Long Term Debt 0.4 10.2 15.2 0.1 0.2 0 0 0 0
Deferred Tax Income 0 0 0 0 0 0 0 0 0
Other Liabilities 0 0.6 0.2 0 0 0 0 0 0
Total Liabilities 18.9 21.7 19.7 1.9 0.9 0.8 0.3 0.6 30.8 K
EQUITY
Common Stock 0.8 18 K 18 K 13.5 K 10.8 K 8.72 K 8.32 K 5.07 K 5 K
Retained Earnings (121.0) (91.0) (63.7) (33.4) (21.3) (13.6) (1.2) (0.3) 48.9 K
Other Accumulative Comprehensive Income/Loss (0.8) (0.7) 1 K 10.7 K 8.52 K 6.53 K 32 K 2.84 K 0
Total Equity 38.1 60.1 80.2 38.8 23.6 16.5 18.1 (0.1) 18.9 K
Total Liabilities and Equity 57.0 81.8 99.9 40.7 24.5 17.4 18.4 0.5 11.9 K
SHARES OUTSTANDING
Common Shares Outstanding 18.0 17.9 16.1 12.0 10.3 11.2 11.2 11.2 11.2